Esomeprazole Cinfa 20 mg gastro-resistant tablets EFG

Spain
Brand name Esomeprazole Cinfa 20 mg gastro-resistant tablets EFG
Form tablets, enteric-coated
Active substance / Dosage
Prescription type Prescription Only Medicine
Registration number 75071
Esomeprazole Cinfa 20 mg gastro-resistant tablets EFG tablets, enteric-coated

Patient Information Leaflet

Introduction

Patient Information Leaflet

esomeprazol cinfa 20 mg gastro-resistant tablets EFG

sodium esomeprazole

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are effects not listed in this leaflet. See section 4.

Leaflet Contents

  1. What esomeprazol cinfa is and what it is used for
  2. What you need to know before taking esomeprazol cinfa
  3. How to take esomeprazol cinfa
  4. Possible side effects
  5. How to store esomeprazol cinfa
  6. Contents of the pack and other information

1. What is esomeprazole cinfa and what is it used for

Esomeprazole cinfa contains a medicine called esomeprazole, which belongs to a group of medicines known as "proton pump inhibitors". These work by reducing the amount of acid produced by the stomach.

Esomeprazole is used to treat the following conditions:

Adults

  • Gastroesophageal reflux disease (GERD). This occurs when stomach acid flows up into the oesophagus (the tube from the throat to the stomach), causing pain, inflammation, and heartburn.
  • Ulcers in the stomach or upper part of the intestine (duodenum) that are infected with a bacterium called Helicobacter pylori. If you have this condition, your doctor will likely also prescribe antibiotics to treat the infection and allow the ulcer to heal.
  • Gastric ulcers caused by medicines called NSAIDs (non-steroidal anti-inflammatory drugs). Esomeprazole may also be used to prevent ulcers from forming if you are taking NSAIDs.
  • Excessive stomach acid caused by a tumour in the pancreas (Zollinger-Ellison syndrome).

Adolescents aged 12 years and older

  • Gastroesophageal reflux disease (GERD). This occurs when stomach acid flows up into the oesophagus (the tube from the throat to the stomach), causing pain, inflammation, and heartburn.
  • Ulcers in the stomach or upper part of the intestine (duodenum) that are infected with a bacterium called Helicobacter pylori. If you have this condition, your doctor will likely also prescribe antibiotics to treat the infection and allow the ulcer to heal.

2. What you need to know before starting to take esomeprazole cinfa

Do not take esomeprazole cinfa

  • If you are allergic to esomeprazole or to any of the other ingredients of this medicine (listed in section 6).
  • If you are allergic to other medicines in the group of proton pump inhibitors (e.g. pantoprazole, lansoprazole, rabeprazol, omeprazole).
  • If you are taking a medicine containing nelfinavir (used in the treatment of HIV infection).
  • If you have ever developed a severe skin rash, skin peeling, blistering, or mouth ulcers after taking esomeprazole or other related medicines.

If any of these situations apply to you, do not take esomeprazole. If you are unsure, consult your doctor or pharmacist before taking esomeprazole cinfa.

Warnings and precautions

Consult your doctor or pharmacist before starting to take esomeprazole cinfa

  • If you have severe liver problems.

  • If you have severe kidney problems.

  • If you have ever had a skin reaction after treatment with a medicine similar to esomeprazole used to reduce stomach acid.

  • If you are scheduled to have a specific blood test (chromogranin A).

Esomeprazole may mask symptoms of other diseases. Therefore, if you experience any of the following events before starting or while taking esomeprazole, contact your doctor immediately:

  • You lose a lot of weight without reason and have difficulty swallowing.
  • You have stomach pain or indigestion.
  • You start vomiting food or blood.
  • Your stools appear black (blood-stained).

If you have been prescribed esomeprazole only to take when symptoms occur, you should contact your doctor if your symptoms persist or change.

Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with esomeprazole treatment. Stop taking esomeprazole and seek immediate medical attention if you notice any symptoms related to these severe skin reactions described in section 4.

Taking a proton pump inhibitor such as esomeprazole, particularly for more than one year, may slightly increase the risk of fracture of the hip, wrist, or spine. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which may increase the risk of osteoporosis).

If you develop a skin rash, especially in areas of skin exposed to sunlight, consult your doctor as soon as possible, as treatment with esomeprazole may need to be discontinued. Remember to mention any other symptoms you may notice, such as joint pain.

Children under 12 years

The use of esomeprazole gastro-resistant tablets is not recommended in children under 12 years of age.

Taking esomeprazole cinfa with other medicines

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

This includes medicines obtained without a prescription. This is because esomeprazole can affect how some medicines work, and some medicines may influence the effect of esomeprazole.

Do not take esomeprazole if you are taking

  • a medicine containing nelfinavir (used for the treatment of HIV infection).

Inform your doctor if you are taking any of the following medicines:

  • Atazanavir (used for the treatment of HIV infection).
  • Clopidogrel (used to prevent blood clots).
  • Ketoconazole, itraconazole, or voriconazole (for fungal infections).
  • Erlotinib (used in cancer treatment).
  • Citalopram, imipramine, clomipramine (for the treatment of depression).
  • Diazepam (used for anxiety, as a muscle relaxant, or for epilepsy).
  • Phenytoin (for epilepsy). If you are taking phenytoin, your doctor will need to monitor when you start or stop taking esomeprazole.
  • Medicines used to thin the blood such as warfarin. Your doctor may need to monitor when you start or stop taking esomeprazole.
  • Cilostazol (used for the treatment of intermittent claudication – leg pain when walking caused by insufficient blood flow).
  • Cisapride (used for indigestion and heartburn).
  • Digoxin (used for heart problems).
  • Methotrexate (a chemotherapeutic agent used at high doses in cancer treatment) – if you are taking high doses of methotrexate, your doctor may temporarily discontinue your esomeprazole treatment.
  • Tacrolimus (organ transplantation).
  • Rifampicin (used for the treatment of tuberculosis).
  • St John’s wort (Hypericum perforatum) (used to treat depression).

If your doctor has prescribed the antibiotics amoxicillin and clarithromycin in addition to esomeprazole for the treatment of Helicobacter pylori-related ulcers, it is very important that you inform your doctor if you are taking any other medicines.

Taking esomeprazole cinfa with food and drink

You may take the tablets with food or on an empty stomach.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

Your doctor will decide whether you can take esomeprazole during this period.

It is unknown whether esomeprazole passes into breast milk. Therefore, esomeprazole should not be taken during breast-feeding.

Driving and using machines

Esomeprazole is unlikely to affect your ability to drive or use tools or machines. However, adverse effects such as dizziness or blurred vision may occur infrequently or rarely (see section 4). You should not drive or operate machinery if you experience any of these effects.

Esomeprazole cinfa contains sodium. This medicine contains less than 23 mg of sodium (1 mmol) per tablet, which is essentially “sodium-free”.

3. How to take esomeprazole cinfa

Follow exactly the instructions for taking this medicine as given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

  • If you take this medicine for a long period of time, your doctor will need to monitor you (especially if you take it for more than one year).
  • If your doctor has instructed you to take this medicine only when you experience symptoms, inform your doctor if the symptoms change.

How much to take

  • Your doctor will have told you how many tablets to take and when to take them. This will depend on your condition, age, and liver function.
  • The recommended doses are indicated below:

Use in adults aged 18 years and older

For the treatment of heartburn caused by gastroesophageal reflux disease (GERD):

  • If your doctor has determined that your esophagus is mildly affected, the recommended dose is one 40 mg esomeprazole tablet once daily for 4 weeks. Your doctor may instruct you to continue taking the same dose for another 4 weeks if your esophagus has not yet healed.

Once the esophagus has healed, the recommended dose is one 20 mg esomeprazole tablet once daily.

  • If your esophagus is not affected, the recommended dose is one 20 mg esomeprazole tablet once daily. Once your condition is under control, your doctor may instruct you to take the medicine only when symptoms occur, up to a maximum of one 20 mg esomeprazole tablet per day.
  • If you have severe liver problems, your doctor may prescribe a lower dose.

For the treatment of ulcers caused by Helicobacter pylori infection and to prevent their recurrence:

  • The recommended dose is one 20 mg esomeprazole tablet twice daily for one week.
  • Your doctor will also prescribe antibiotics, such as amoxicillin and clarithromycin.

For the treatment of gastric ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs):

  • The recommended dose is one 20 mg esomeprazole tablet once daily for 4 to 8 weeks.

For the prevention of gastric ulcers in patients taking NSAIDs (non-steroidal anti-inflammatory drugs):

  • The recommended dose is one 20 mg esomeprazole tablet once daily.

For the treatment of excessive stomach acid caused by a pancreatic tumor (Zollinger-Ellison syndrome):

  • The recommended dose is 40 mg of esomeprazole twice daily.
  • Your doctor will adjust the dose according to your needs and will also decide how long you should take this medicine. The maximum dose is 80 mg twice daily.

Use in adolescents aged 12 years and older

For the treatment of heartburn caused by gastroesophageal reflux disease (GERD):

  • If your doctor has determined that your esophagus is mildly affected, the recommended dose is one 40 mg esomeprazole tablet once daily for 4 weeks. Your doctor may instruct you to continue taking the same dose for another 4 weeks if your esophagus has not yet healed.
  • Once the esophagus has healed, the recommended dose is one 20 mg esomeprazole tablet once daily.
  • If your esophagus is not affected, the recommended dose is one 20 mg esomeprazole tablet once daily.
  • If you have severe liver problems, your doctor may prescribe a lower dose.

For the treatment of ulcers caused by Helicobacter pylori infection and to prevent their recurrence:

  • The recommended dose is one 20 mg esomeprazole tablet twice daily for one week.
  • Your doctor will also prescribe antibiotics, such as amoxicillin and clarithromycin.

How to take this medicine

  • You may take the tablets at any time of day.
  • You may take the tablets with food or on an empty stomach.
  • Swallow the tablets whole with a glass of water. Do not chew or crush the tablets. This is because the tablets contain coated granules that protect the medicine from being destroyed by stomach acid. It is important not to damage the granules.

What to do if you have difficulty swallowing

  • If you have difficulty swallowing the tablets:
  • Place the tablets in a glass of still (non-carbonated) water. Do not use any other liquid.
  • Stir until the tablets disintegrate (the solution will not be clear). You may drink the mixture immediately or within 30 minutes. Always stir well just before drinking.
  • To ensure you have taken all the medicine, rinse the glass thoroughly with half a glass of water and drink it. The solid particles contain the medicine – do not chew or crush the granules.
  • If you are completely unable to swallow, the tablets may be dispersed in water and administered via a syringe directly into the stomach through a tube (gastric tube).

Use in children under 12 years of age

Esomeprazole gastro-resistant tablets are not recommended for children under 12 years of age.

Elderly patients

Dosage adjustment is not necessary in elderly patients.

If you take more esomeprazole cinfa than you should

If you take more esomeprazole than your doctor has prescribed, consult your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at telephone number: 91 562 04 20, stating the medicine and the amount ingested.

If you forget to take esomeprazole cinfa

  • If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, do not take the missed dose.
  • Do not take a double dose to make up for a missed dose.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

If you notice any of the following serious adverse effects, stop taking esomeprazole and contact a doctor immediately:

  • Sudden difficulty breathing, swelling of the lips, tongue or throat, or swelling of the entire body, skin rash, fainting, or difficulty swallowing (severe allergic reaction).
  • Skin redness with blistering or peeling. Severe blisters and bleeding of the lips, eyes, mouth, nose, and genitals may also occur. This could be “Stevens-Johnson syndrome” or “toxic epidermal necrolysis”.
  • Yellowing of the skin, dark urine, and fatigue, which may be symptoms of liver problems.
  • Widespread rash, high body temperature, and enlarged lymph nodes (DRESS syndrome or drug hypersensitivity syndrome), which is very rarely observed.

These effects are rare and may affect up to 1 in 1,000 people.

Other adverse effects include:

Frequent (may affect up to 1 in 10 people)

  • Headache.
  • Stomach or intestinal effects: stomach pain, constipation, diarrhoea, gas (flatulence).
  • Nausea or vomiting.
  • Benign polyps in the stomach.

Uncommon (may affect up to 1 in 100 people)

  • Swelling of feet and ankles.
  • Sleep disturbance (insomnia).
  • Dizziness, tingling and numbness, drowsiness.
  • Dizziness or vertigo.
  • Dry mouth.
  • Abnormal blood test results indicating liver function.
  • Skin rash, hives, skin itching.
  • Fracture of hip, wrist or spine (if esomeprazole is used at high doses and for a long period).

Rare (may affect up to 1 in 1,000 people)

  • Blood disorders such as a decrease in the number of white blood cells or platelets. This may cause weakness, bruising, or increase the likelihood of infections.
  • Low sodium levels in the blood. This may cause weakness, vomiting, and cramps.
  • Restlessness, confusion, or depression.
  • Taste disturbances.
  • Eye disorders such as blurred vision.
  • Sudden sensation of breathlessness or difficulty breathing (bronchospasm).
  • Inflammation inside the mouth.
  • A fungal infection known as “candidiasis” that may affect the oesophagus.
  • Liver problems including jaundice, which may cause yellowing of the skin, dark urine, and fatigue.
  • Hair loss (alopecia).
  • Sunlight-induced dermatitis.
  • Joint pain (arthralgia) or muscle pain (myalgia).
  • General feeling of malaise and lack of energy.
  • Increased sweating.

Very rare (may affect up to 1 in 10,000 people)

  • Changes in blood cell counts, including agranulocytosis (reduction in white blood cells).
  • Aggression.
  • Seeing, feeling or hearing things that are not real (hallucinations).
  • Liver disorders that may lead to liver failure or brain inflammation.
  • Sudden onset of severe skin rash, blistering or peeling of the skin. These symptoms may be accompanied by high fever and joint pain. (Erythema multiforme, Stevens-Johnson syndrome, Toxic epidermal necrolysis).
  • Muscle weakness.
  • Severe kidney disorders.
  • Enlargement of the breasts in men.

Frequency not known (cannot be estimated from available data)

  • If you are being treated with esomeprazole for more than three months, your blood magnesium levels may decrease. Low magnesium levels may present as fatigue, involuntary muscle contractions, disorientation, seizures, dizziness, or increased heart rate. If you experience any of these symptoms, inform your doctor immediately. Low magnesium levels may also lead to reduced levels of potassium or calcium in the blood. Your doctor may decide to perform periodic blood tests to monitor your magnesium levels.
  • Inflammation of the intestine (which may lead to diarrhoea).
  • Skin rash, possibly accompanied by joint pain.

In very rare cases, esomeprazole may affect white blood cells, causing immune deficiency. If you develop an infection with symptoms such as fever accompanied by a severe deterioration in general condition, or fever with signs of a local infection such as neck, throat or mouth pain, or difficulty urinating, you should consult your doctor as soon as possible to rule out a reduction in white blood cells (agranulocytosis) by means of a blood test. It is important that, in this case, you inform your doctor about your medication.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of esomeprazole cinfa

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the label, carton or blister after EXP. The expiry date refers to the last day of the month indicated.

Blister packs

Do not store above 30°C.

Keep in the original packaging to protect from moisture.

Vials:

Do not store above 30°C.

Shelf life after first opening of the vial: 100 days

Keep the vial tightly closed to protect from moisture.

Medicines should not be disposed of via wastewater or household waste. Return unused medicines and their packaging to the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of medicines and packaging you no longer need. This helps protect the environment.

6. Package contents and other information

Composition of esomeprazol cinfa

  • The active substance is esomeprazole. It contains 20 mg of esomeprazole (as sodium esomeprazole).

  • The other components are:

  • Core: Microcrystalline cellulose spheres (microcrystalline cellulose and water), hypromellose (E464), talc (E553b), titanium dioxide (E171), glycerol monostearate, polysorbate 80, methacrylic acid-ethyl acrylate copolymer (1:1) dispersion at 30% (sodium lauryl sulfate, polysorbate 80 and methacrylic acid-ethyl acrylate copolymer), triethyl citrate (E1505), macrogol, microcrystalline cellulose (E460i), crospovidone (type A) and sodium stearyl fumarate.

  • Coating: Opadry II Light Blue 85F30663 (partially hydrolysed polyvinyl alcohol, titanium dioxide, macrogol, talc, indigo carmine aluminum lake / FD&C Blue #2 (E132) and yellow iron oxide (E172)).

Appearance of the medicinal product and contents of the container

Esomeprazol cinfa 20 mg are blue, oval-shaped, gastro-resistant tablets.

It is available in packs of 14, 28, 56 and 100 tablets (clinical pack) in blister and bottle.

Only certain pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta.

31620 Huarte (Navarra) - Spain

Manufacturer

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta.

31620 Huarte (Navarra) - Spain

or

TOWA PHARMACEUTICAL EUROPE S.L.

C/ San Martí, 75-97

Martorelles, 08107 Barcelona

Spain

Date of the most recent revision of this leaflet: January 2025

Detailed information on this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/

You can access detailed and up-to-date information about this medicine by scanning with your mobile phone (smartphone) the QR code included in the leaflet and packaging. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/75071/P_75071.html

QR code link: https://cima.aemps.es/cima/dochtml/p/75071/P_75071.html

This information is intended for healthcare professionals only:

Administration via gastric tube

  1. Place the tablet into a suitable syringe and fill the syringe with approximately 25 ml of water and approximately 5 ml of air. For certain tubes, a dispersion in 50 ml of water is required to prevent the pellets from blocking the tube.
  2. Shake the syringe immediately for about 2 minutes to disperse the tablet.
  3. Hold the syringe with the tip facing upwards and check that the tip is not blocked.
  4. Connect the syringe to the tube while maintaining the previous position.
  5. Shake the syringe and place it with the tip facing downwards. Immediately inject 5–10 ml into the tube.

After injection, invert the syringe and shake it (the syringe must be kept with the tip facing upwards to prevent blockage of the tip).

  1. Place the syringe back with the tip facing downwards and immediately inject another 5–10 ml into the tube. Repeat this procedure until the syringe is empty.
  2. Fill the syringe with 25 ml of water and 5 ml of air and repeat step 5 if necessary to flush any remaining sediment from the syringe. For certain tubes, 50 ml of water may be required.